View Item 

Show simple item record

Modifier genes for disorders of thrombosis and hemostasis
dc.contributor.authorWestrick, Randal Josephen_US
dc.contributor.authorGinsburg, David W.en_US
dc.date.accessioned2010-06-01T18:54:50Z
dc.date.available2010-06-01T18:54:50Z
dc.date.issued2009-07en_US
dc.identifier.citationWESTRICK, R. J.; GINSBURG, D. (2009). "Modifier genes for disorders of thrombosis and hemostasis." Journal of Thrombosis and Haemostasis 7(s1 State of the Art 2009 ): 132-135. <http://hdl.handle.net/2027.42/72106>en_US
dc.identifier.issn1538-7933en_US
dc.identifier.issn1538-7836en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72106
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19630785&dopt=citationen_US
dc.format.extent131469 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2009 International Society on Thrombosis and Haemostasisen_US
dc.subject.otherADAMTS13en_US
dc.subject.otherFactor V Leidenen_US
dc.subject.otherGenetic Modelen_US
dc.subject.otherHemostasisen_US
dc.subject.otherMiceen_US
dc.subject.otherVon Willebrand Factoren_US
dc.titleModifier genes for disorders of thrombosis and hemostasisen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum* Department of Human Genetics, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationum† Departments of Internal Medicine and Human Genetics, Howard Hughes Medical Institute, Life Sciences Institute, University of Michigan, Ann Arbor MI, USAen_US
dc.identifier.pmid19630785en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72106/1/j.1538-7836.2009.03362.x.pdf
dc.identifier.doi10.1111/j.1538-7836.2009.03362.xen_US
dc.identifier.sourceJournal of Thrombosis and Haemostasisen_US
dc.identifier.citedreferenceDavidson CJ, Tuddenham EG, McVey JH. 450 million years of hemostasis. J Thromb Haemost 2003; 1: 1487 – 94.en_US
dc.identifier.citedreferenceGinsburg D. Hemophilia and Other Disorders of Hemostasis. Emery and Rimoin’s Principles and Practice of Medical Genetics, 5th edn. New York: Churchill Livingstone, 2007.en_US
dc.identifier.citedreferenceGinsburg D. Identifying novel genetic determinants of hemostatic balance. J Thromb Haemost 2005; 3: 1561 – 8.en_US
dc.identifier.citedreferenceHoulston RS, Tomlinson IP. Modifier genes in humans: strategies for identification. Eur J Hum Genet 1998; 6: 80 – 8.en_US
dc.identifier.citedreferenceHoover-Plow JL, Shchurin A, Hart E, Sha J, Singer JB, Hill AE, Nadeau JH. Genetic background determines response to hemostasis and thrombosis. BMC Blood Disord 2006; 6: 6.en_US
dc.identifier.citedreferenceSa Q, Hart E, Hill AE, Nadeau JH, Hoover-Plow JL. Quantitative trait locus analysis for hemostasis and thrombosis. Mamm Genome 2008; 19: 406 – 12.en_US
dc.identifier.citedreferenceRosen ED, Xuei X, Suckow M, Edenberg H. Searching for hemostatic modifier genes affecting the phenotype of mice with very low levels of FVII. Blood Cells Mol Dis 2006; 36: 131 – 4.en_US
dc.identifier.citedreferenceLemmerhirt HL, Broman KW, Shavit JA, Ginsburg D. Genetic regulation of plasma von Willebrand factor levels: QTL analysis in a mouse model. J Thromb Haemost 2006; 5: 329 – 35.en_US
dc.identifier.citedreferenceLemmerhirt HL, Shavit JA, Levy GG, Cole SM, Long JC, Ginsburg D. Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene. Blood 2006; 108: 3061 – 7.en_US
dc.identifier.citedreferenceWestrick RJ, Winn ME, Eitzman DT. Murine models of vascular thrombosis. Arterioscler Thromb Vasc Biol 2007; 27: 2079 – 93.en_US
dc.identifier.citedreferenceFrazer KA, Eskin E, Kang HM, Bogue MA, Hinds DA, Beilharz EJ, Gupta RV, Montgomery J, Morenzoni MM, Nilsen GB, Pethiyagoda CL, Stuve LL, Johnson FM, Daly MJ, Wade CM, Cox DR. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 2007; 448: 1050 – 3.en_US
dc.identifier.citedreferencePeters LL, Zhang W, Lambert AJ, Brugnara C, Churchill GA, Platt OS. Quantitative trait loci for baseline white blood cell count, platelet count, and mean platelet volume. Mamm Genome 2005; 16: 749 – 63.en_US
dc.identifier.citedreferenceMohlke KL, Nichols WC, Westrick RJ, Novak EK, Cooney KA, Swank RT, Ginsburg D. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. Proc Natl Acad Sci USA 1996; 93: 15352 – 7.en_US
dc.identifier.citedreferenceSweeney JD, Novak EK, Reddington M, Takeuchi KH, Swank RT. The RIIIS/J inbred mouse strain as a model for von Willebrand disease. Blood 1990; 76: 2258 – 65.en_US
dc.identifier.citedreferenceMohlke KL, Purkayastha AA, Westrick RJ, Smith PL, Petryniak B, Lowe JB, Ginsburg D. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell 1999; 96: 111 – 20.en_US
dc.identifier.citedreferenceJohnsen JM, Levy GG, Westrick RJ, Tucker PK, Ginsburg D. The endothelial-specific regulatory mutation, Mvwf1, is a common mouse founder allele. Mamm Genome 2008; 19: 32 – 40.en_US
dc.identifier.citedreferenceJohnsen JM, Teschke M, Pavlidis P, McGee BM, Tautz D, Ginsburg D, Baines JF. Selection on cis-regulatory variation at B4galnt2 and its influence on von Willebrand Factor in house mice. Mol Biol Evol 2008; 26: 567 – 78.en_US
dc.identifier.citedreferenceWright MW, Bruford EA. Human and orthologous gene nomenclature. Gene 2006; 369: 1 – 6.en_US
dc.identifier.citedreferenceLevy GG, Motto DG, Ginsburg D. ADAMTS13 turns 3. Blood 2005; 106: 11 – 7.en_US
dc.identifier.citedreferenceMotto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 2005; 115: 2752 – 61.en_US
dc.identifier.citedreferenceBertina RM. Genetic approach to thrombophilia. Thromb Haemost 2001; 86: 92 – 103.en_US
dc.identifier.citedreferenceBertina RM. Molecular risk factors for thrombosis. Thromb Haemost 1999; 82: 601 – 9.en_US
dc.identifier.citedreferenceSouto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 2000; 67: 1452 – 9.en_US
dc.identifier.citedreferenceBezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, et al. Gene variants associated with deep vein thrombosis. JAMA 2008; 299: 1306 – 14.en_US
dc.identifier.citedreferenceCui J, Eitzman DT, Westrick RJ, Christie PD, Xu ZJ, Yang AY, Purkayastha AA, Yang TL, Metz AL, Gallagher KP, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood 2000; 96: 4222 – 6.en_US
dc.identifier.citedreferenceEitzman DT, Westrick RJ, Bi X, Manning SL, Wilkinson JE, Broze GJ, Ginsburg D. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation 2002; 105: 2139 – 42.en_US
dc.identifier.citedreferenceTsipouri V, Curtin JA, Nolan PM, Vizor L, Parsons CA, Clapham CM, Latham ID, Rooke LJ, Martin JE, Peters J, et al. Three Novel Pigmentation Mutants Generated by Genome-Wide Random ENU Mutagenesis in the Mouse. Comp Funct Genomics 2004; 5: 123 – 7.en_US
dc.identifier.citedreferenceHardisty RE, Erven A, Logan K, Morse S, Guionaud S, Sancho-Oliver S, Hunter AJ, Brown SD, Steel KP. The deaf mouse mutant Jeff (Jf) is a single gene model of otitis media. J Assoc Res Otolaryngol 2003; 4: 130 – 8.en_US
dc.identifier.citedreferenceVitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, McDonald JD, Dove WF, Pinto LH, Turek FW, Takahashi JS. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science 1994; 264: 719 – 25.en_US
dc.identifier.citedreferenceBeutler B, Du X, Xia Y. Precis on forward genetics in mice. Nat Immunol 2007; 8: 659 – 64.en_US
dc.identifier.citedreferenceCarpinelli MR, Hilton DJ, Metcalf D, Antonchuk JL, Hyland CD, Mifsud SL, Di Rago L, Hilton AA, Willson TA, Roberts AW, et al. Suppressor screen in Mpl−/− mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc Natl Acad Sci USA 2004; 101: 6553 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1538-7836.2009.03362.x.pdf
Size:
128.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.